IDSA releases a new recommendation on anakinra and updated remarks for the existing recommendation on the use of nirmatrelvir/ritonavir in the treatment of patients with COVID-19.
We have come a long way since Jan. 31, 2020, when the COVID-19 pandemic was first declared a public health emergency, but none of us will ever forget how the pandemic changed our nation and impacted the lives of so many people.
Members can now register and make hotel reservations for IDWeek 2023 in Boston Oct. 11-15. Surround yourself with your ID community and attend sessions addressing ID’s most pressing issues. Register now using member rates and get the best hotel selections before registration opens to the public. You belong at IDWeek, and we can’t wait to see you there!